Recent Advances in T-Cell Lymphoma: A Conversation with Dr. Steven Horwitz

·

In this podcast, Dr. Steven Horwitz of  Memorial Sloan Kettering Cancer Center discusses recent progress in the treatment and management of T-cell lymphoma. Listen now to hear more!

Continue reading

Improving the Management of Metastatic Breast Cancer: A Conversation With Dr. Sara Tolaney

· Keira Smith: Welcome to Oncology Data AdvisorTM, where we explore the latest advances in cancer research and treatment. I'm Keira Smith. In this podcast, Dr. Sara Tolaney from Dana-Farber Cancer Institute will be discussing strategies for improving the management of patients with metastatic breast cancer. Thank you for joining us, Dr. Tolaney. Sara Tolaney, MD, MPH: Thanks so much for having me. I'm Sara Tolaney. I'm a breast medical oncologist at Dana-Farber Cancer Institute here in Bo...
Continue reading

The Promising Effects of Patient-Reported Symptom Data on Survival and Well-Being: A Conversation With Dr. Kelly Brassil

Welcome to Oncology Data Advisor, where we explore the latest advances in cancer research and treatment. I am Selma Khenissi from i3 Health. In this podcast, Dr. Kelly Brassil, PhD, RN, from The University of Texas MD Anderson Cancer Center, will be discussing patient-reported symptom data and how it affects patient survival and quality of life. Selma Khenissi, MPS: Can you comment on how tools such as Project Patient Voice positively impact the outcomes of patients with classical Hodgkin lympho...
Continue reading

Update on Immunotherapeutic Strategies for Recurrent and Metastatic Cervical Cancer

There are an estimated 13,800 new cases of cervical cancer in the United States each year, and 4,290 people die of the disease (ACS, 2020). Deaths have declined during the past few decades due to screening and heightened awareness, yet this malignancy continues to be a global health concern and is considered an epidemic in parts of the world. A significant proportion of patients develop advanced disease, which is rarely curable with available therapies, and treatment is often limited to palliati...
Continue reading

Rethinking the Management of Differentiated and Anaplastic Thyroid Cancers With Jochen Lorch, MD, MSc, and Carolyn Grande, CRNP, AOCNP®

Oncology Data Advisor™ · Rethinking the Management of Differentiated and Anaplastic Thyroid Cancers Thyroid cancer is one of the most prevalent cancers in the United States. An estimated 44,280 new cases are diagnosed annually, and 2,200 people die of the disease (ACS, 2021). Thyroid cancer is typically more aggressive in men than in women and becomes increasingly lethal in those above the age of 40 (NCCN, 2021). There are three primary subtypes: differentiated (including papillary,...
Continue reading

Subscribe

Get the latest updates delivered to your inbox!

Follow Us

Copyright © 2021 Oncology Data Advisor. All rights reserved.